AK Medical Holdings Limited (HKG:1789)
Hong Kong
· Delayed Price · Currency is HKD 6.08
-0.15 (-2.41%)
Apr 3, 2025, 4:08 PM HKT
AK Medical Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,346 | 1,094 | 1,052 | 761.44 | 1,035 | Upgrade
|
| Revenue Growth (YoY) | 23.09% | 3.98% | 38.16% | -26.46% | 11.73% | Upgrade
|
| Cost of Revenue | 538.18 | 419.38 | 415.61 | 262.25 | 320.85 | Upgrade
|
| Gross Profit | 808.19 | 674.49 | 636.44 | 499.19 | 714.53 | Upgrade
|
| Selling, General & Admin | 384.86 | 352.25 | 298.42 | 292.66 | 237.12 | Upgrade
|
| Research & Development | 139.21 | 137.13 | 110.87 | 113.07 | 104.97 | Upgrade
|
| Other Operating Expenses | -16.65 | -26.37 | -11.19 | -5.98 | -5.33 | Upgrade
|
| Operating Expenses | 507.41 | 463 | 398.09 | 399.75 | 336.76 | Upgrade
|
| Operating Income | 300.78 | 211.48 | 238.34 | 99.44 | 377.77 | Upgrade
|
| Interest Expense | - | -1.29 | -2.17 | -1.61 | -1.28 | Upgrade
|
| Interest & Investment Income | 22.44 | 22.77 | 17.75 | 8.99 | 12.96 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.4 | -1.85 | 4.73 | 1.74 | -4 | Upgrade
|
| EBT Excluding Unusual Items | 319.82 | 231.12 | 258.65 | 108.56 | 385.46 | Upgrade
|
| Impairment of Goodwill | - | - | -18.36 | - | -8.85 | Upgrade
|
| Pretax Income | 319.82 | 231.12 | 240.29 | 108.56 | 376.61 | Upgrade
|
| Income Tax Expense | 45.9 | 49.01 | 35.52 | 15.94 | 62.6 | Upgrade
|
| Net Income | 273.93 | 182.1 | 204.77 | 92.62 | 314.01 | Upgrade
|
| Net Income to Common | 273.93 | 182.1 | 204.77 | 92.62 | 314.01 | Upgrade
|
| Net Income Growth | 50.42% | -11.07% | 121.09% | -70.50% | 17.61% | Upgrade
|
| Shares Outstanding (Basic) | 1,116 | 1,113 | 1,109 | 1,113 | 1,102 | Upgrade
|
| Shares Outstanding (Diluted) | 1,119 | 1,119 | 1,117 | 1,121 | 1,107 | Upgrade
|
| Shares Change (YoY) | -0.05% | 0.15% | -0.28% | 1.21% | 4.61% | Upgrade
|
| EPS (Basic) | 0.25 | 0.16 | 0.18 | 0.08 | 0.28 | Upgrade
|
| EPS (Diluted) | 0.24 | 0.16 | 0.18 | 0.08 | 0.28 | Upgrade
|
| EPS Growth | 50.00% | -11.11% | 125.00% | -71.43% | 12.00% | Upgrade
|
| Free Cash Flow | - | -149.86 | 127.72 | 117.86 | 120.01 | Upgrade
|
| Free Cash Flow Per Share | - | -0.13 | 0.11 | 0.10 | 0.11 | Upgrade
|
| Dividend Per Share | 0.068 | 0.041 | 0.053 | 0.020 | 0.034 | Upgrade
|
| Dividend Growth | 65.64% | -23.04% | 160.59% | -39.53% | -49.76% | Upgrade
|
| Gross Margin | 60.03% | 61.66% | 60.49% | 65.56% | 69.01% | Upgrade
|
| Operating Margin | 22.34% | 19.33% | 22.66% | 13.06% | 36.49% | Upgrade
|
| Profit Margin | 20.34% | 16.65% | 19.46% | 12.16% | 30.33% | Upgrade
|
| Free Cash Flow Margin | - | -13.70% | 12.14% | 15.48% | 11.59% | Upgrade
|
| EBITDA | 371.66 | 282.36 | 300.3 | 156.85 | 421.38 | Upgrade
|
| EBITDA Margin | 27.61% | 25.81% | 28.54% | 20.60% | 40.70% | Upgrade
|
| D&A For EBITDA | 70.88 | 70.88 | 61.95 | 57.42 | 43.6 | Upgrade
|
| EBIT | 300.78 | 211.48 | 238.34 | 99.44 | 377.77 | Upgrade
|
| EBIT Margin | 22.34% | 19.33% | 22.66% | 13.06% | 36.49% | Upgrade
|
| Effective Tax Rate | 14.35% | 21.21% | 14.78% | 14.68% | 16.62% | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.